TAT 2016
 
Monday, March 21, 2016
9:00 am - 10:15 amPlenary Session 1: Opening Ceremony
Chair: Jean-Pierre Armand, Cancer Institute Gustave Roussy
Chair: Giuseppe Giaccone, Georgetown University
10:40 am - 12:00 pmPlenary Session 2: Immuno-oncology (1)
Chair: Michael Atkins, Geogetown-Lombardi Comprehensive Cancer Center
Chair: Gail Eckhardt, University of Colorado Cancer Center
1:00 pm - 2:30 pmPlenary Session 3: Phase 1 Studies - Completed or in Progress (miscellaneous drugs & targets)
Chair: Lesley Seymour, Queen's University
Chair: Shivaani Kummar, Stanford University Cancer Institute
2:55 pm - 4:35 pmPlenary Session 4: New Drugs and Targets in Hemato-Oncology
Chair: Yves Pommier, National Cancer Institute
Chair: Filippo de Braud, Fondazione IRCCS Istituto Nazionale dei Tumori
4:45 pm - 5:45 pmSpecial Symposium (non-CME) Immuno-Oncology and Third-Generation Tyrosine Kinase Inhibitors Company Updates
Chair: Hilary Calvert, UCL Cancer Institute
Chair: Jean-Pierre Armand, Cancer Institute Gustave Roussy
6:00 pm - 7:00 pmPoster Viewing & Welcome Reception
 
Tuesday, March 22, 2016
8:50 am - 10:20 amPlenary Session 5: Immuno-oncology (2)
Chair: Antoine Italiano, Institut Bergonié
Chair: Filip Janku, MD Anderson Cancer Center
10:45 am - 12:15 pmPlenary Session 6: Targeting Difficult Targets
Chair: Geoffrey Shapiro, Dana-Farber Cancer Institute
Chair: Donald Bottaro, National Cancer Institute
12:15 pm - 1:15 pmMeet-the-professor session: How to give a talk and how to write a paper
Lee Ellis, MD Anderson Cancer Center
1:15 pm - 2:55 pmPlenary Session 7: Cell Cycle and DNA Targets
Chair: Michael Pishvaian, Georgetown University
Chair: Hilary Calvert, UCL Cancer Institute
3:20 pm - 5:00 pmPlenary Session 8: Drug penetration into the Central Nervous System
Chair: Susan Bates, Columbia University Medical Center
Chair: Antoine Italiano, Institut Bergonié
 
Wednesday, March 23, 2016
8:30 am - 9:45 amPlenary Session 9: Drug Development Methodology
Chair: Jean-Charles Soria, Cancer Institute Gustave Roussy
Chair: Lee Ellis, MD Anderson Cancer Center
10:15 am - 12:15 pmPlenary Session 10: Miscellaneous Drugs and Targets (1)
Chair: Anthony Tolcher, South Texas Accelerated Research Therapeutics
Chair: Keith Flaherty, Massachusetts General Hospital
1:00 pm - 3:00 pmPlenary Session 11: Miscellaneous Drugs and Targets (2)
Chair: Udai Banerji, The Institute of Cancer Research
Chair: Arne Östman, Karolinska Institutet
3:05 pm - 3:10 pmClosing remarks
Giuseppe Giaccone, Georgetown University